Showing results (81-90 of 117) with videos related to
Sort By:
Pageof 12
Biomaterials Advances|November 18, 2023
In vivo investigation of boron-rich nanodrugs for treating triple-negative breast cancers via boron neutron capture therapyKai-Wei Lan, Wei-Yuan Huang, Yi-Lin Chiu, et al.Biomacromolecules|June 7, 2024
Boron Neutron Capture Therapy Enhanced by Boronate Ester Polymer Micelles: Synthesis, Stability, and Tumor Inhibition StudiesWan Yun Fu, Yi-Lin Chiu, Shi-Chih Huang, et al.The American Journal of Chinese Medicine|February 29, 2020
Ginkgo biloba Induces Thrombomodulin Expression and Tissue-Type Plasminogen Activator Secretion via the Activation of Krüppel-Like Factor 2 within Endothelial CellsYi-Lin Chiu, Wei-Che Tsai, Chih-Hsien Wu, et al.Journal of Agricultural and Food Chemistry|October 30, 2010
GMI, a Ganoderma immunomodulatory protein, down-regulates tumor necrosis factor α-induced expression of matrix metalloproteinase 9 via NF-κB pathway in human alveolar epithelial A549 cellsChing-Hsiung Lin, Yi-Min Hsiao, Chu-Chyn Ou, et al.Journal of Inflammation Research|August 31, 2022
Assessing the Global Impact on the Mouse Kidney After Traumatic Brain Injury: A Transcriptomic StudyWei-Hung Chan, Yu-Juei Hsu, Chiao-Pei Cheng, et al.Clinical Pharmacology in Drug Development|April 29, 2016
Clinical Safety, Pharmacokinetics, and Pharmacodynamics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 in Healthy Volunteers and Elderly AdultsWei Liu, David A Katz, Charles Locke, et al.Clinical Pharmacokinetics|February 20, 2016
Drug-Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy VolunteersAkshanth R Polepally, Jennifer R King, Bifeng Ding, et al.Psychopharmacology|September 9, 2011
The scopolamine model as a pharmacodynamic marker in early drug developmentRobert A Lenz, Jeffrey D Baker, Charles Locke, et al.Antimicrobial Agents and Chemotherapy|October 14, 2015
Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-RitonavirPrajakta S Badri, Sandeep Dutta, Haoyu Wang, et al.Cancers|September 10, 2021
Targeting S1PR1 May Result in Enhanced Migration of Cancer Cells in Bladder CarcinomaChin-Li Chen, En Meng, Sheng-Tang Wu, et al.Pageof 12